The Scottish developer of optical molecular imaging technology, Edinburgh Molecular Imaging, has received venture capital funding amounting to more than $6 million, the University of Edinburgh announced Feb 7.

While noise reduction significantly improves the quantitative image quality in simulated large patients undergoing abdominal CT in comparison with filtered back projection, no improvement was seen for low-contrast detectability, according to a study published in the February issue of the American Journal of Roentgenology.

Adrenoceptor blockers have been found to stave off metastasis and recurrence of breast cancer. This may be due to their interruption of key genes involved in glucose metabolism as visualized by FDG-PET, according to a study published Feb. 6 in the Journal of Nuclear Medicine.

An extended follow up of the Canadian National Breast Screening Study (CNBSS) found that annual mammography does not reduce breast cancer mortality for women aged 40-59 beyond what is achieved with usual care and physical examination, according to results published Feb. 11 in the British Medical Journal (BMJ).

Physicians may be able to more accurately select treatments that will target genomic alterations in women with advanced breast cancer, according to a study published online Feb. 7 by The Lancet Oncology. The study’s findings could also aid in clinical trial design and drug development. 

The American Society for Radiation Oncology (ASTRO) and the Society of Surgical Oncology (SSO) have published a consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer.

Though overall rates of CT use have slowed, spinal CT use continues to rise, suggesting the need for an examination of its utility, according to a study published in the February issue of the Journal of the American College of Radiology.

PET/MR doesn’t appear to provide any additional insight beyond PET/CT for thoracic staging of non-small cell lung cancer, according to a study published Feb. 6 in the Journal of Nuclear Medicine.